Key exclusion criteria were a change in body weight of more than 5 kg within 90 days before screening, a history of type 1 diabetes (T1D), use of a GLP-1 RA within 90 days before screening, and uncontrolled diabetic retinopathy [61]. This evidence concerns the gene GCG and type 1 diabetes mellitus.